Specialist Updates 
Oncology

CAR T-cell therapy to be funded for three lymphomas

Australia to be one of the few countries to manufacture the treatment
Clare Pain
0
3 February 2020
Save
ClosePlease login
Peter MacCallum Cancer Centre
The Peter MacCallum Cancer Centre in Melbourne.

Chimeric antigen receptor (CAR) T-cell therapy for certain relapsed and refractory patients with three types of lymphoma will be publicly funded, Minister for Health Greg Hunt has announced.

Eligible patients will be certain adults with diffuse large B-cell lymphoma or the rarer conditions of transformed follicular lymphoma and primary mediastinal B-cell lymphoma.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .